The Pharmaceutical Compliance

“By-laws revision-section 5.04 -terms for trustees: a.previous: 2 year terms, 3 trustees elected each year b.revision: 3 year terms, 2 trustees elected each year vote conducted during annual business meeting on march 1, 2017. Voice vote was requested. Unanimous affirmation, with no opposing votes”

“Pcf has one class of members, designated as corporate members. Corporate memberships shall be conferred upon application and on compliance with the standards and requirements set forth in the by-laws, and approval by majority vote of the board of trustees.”

“Each corporate member shall have voting rights equal to all other corporate members. Each corporate member may cast its vote by any officer or agent of the corporate member. Each corporate member is entitled to one vote. The members of the board of trustees shall be elected by the corporate members entitled to vote at the annual business meeting of the members.”

“Any action required or permitted to be taken at a meeting of members may be taken without a meeting if all the members entitled to vote theron consent thereto in writing, except that in the case of any action to be taken relating to a merger, consolidation and sale of assets, the action may be taken without a meeting only (1) if all member consent thereto in writing; or (2) if (a) all members entitled to vote theron consent thereto in writing, (b) the corporation provides to all other members advance notification setting forth the proposed action consented to, (c) the proposed action is not consummated before the expiration of ten days after the giving of the notice, and (d) the notice sets forth the existence of the ten day period.”

“A copy of the 990 is provided to the board for review prior to filing.”

“Copies of governing documents are available upon request.”

“The purpose of the pharmaceutical compliance forum, inc. Is to promote, advance, and share best practices, promoting higher business standards and better business methods regarding pharmaceutical compliance, including but not limited to compliance programs relating to pharmaceutical, biologics and devices manufacturers, developers, marketers, and sellers, and to do and engage in any and all activities that may be necessary or incidental to any or all of the foregoing purposes.”